Unified Balance Scale: an activity-based, bed to community, and aetiology-independent measure of balance calibrated with Rasch analysis. La Porta F, Franceschini M, Caselli S, Cavallini P, Susassi S, Tennant A. J Rehabil Med. 2011 Apr;43(5):435-44.
Unified Balance Scale: classic psychometric and clinical properties. La Porta F, Franceschini M, Caselli S, Susassi S, Cavallini P, Tennant A. J Rehabil Med. 2011 Apr;43(5):445-53.
Unlocking the potential of natriuretic peptide testing in primary care: a roadmap for early heart failure diagnosis. Bayes-Genis A, Rosano G. Eur J Heart Fail. 2023 Jun 27. doi: 10.1002/ejhf.2950. Online ahead of print. PMID: 37369971 No abstract available.
Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease. Wolf C, Lorenzen JM, Stein S, Tsikas D, Störk S, Weidemann F, Ertl G, Anker SD, Bauersachs J, Thum T. Int J Cardiol. 2012 May 3;156(3):289-94.
Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Lorenzen JM, Volkmann I, Fiedler J, Schmidt M, Scheffner I, Haller H, Gwinner W, Thum T. Am J Transplant. 2011 Oct;11(10):2221-7.
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. von Haehling S, Schefold JC, Jankowska EA, Springer J, Vazir A, Kalra PR, Sandek A, Fauler G, Stojakovic T, Trauner M, Ponikowski P, Volk HD, Doehner W, Coats AJ, Poole-Wilson PA, Anker SD. J Am Coll Cardiol. 2012 Feb 7;59(6):585-92.
Ursodeoxycholic acid treatment in a rat model of cancer cachexia. Tschirner A, von Haehling S, Palus S, Doehner W, Anker SD, Springer J. J Cachexia Sarcopenia Muscle. 2012 Mar;3(1):31-6.
Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry. Cappelletto C, Stolfo D, Orsini N, Benson L, Rodolico D, Rosano GMC, Dahlström U, Sinagra G, Lund LH, Savarese G. Eur J Heart Fail. 2023 May;25(5):698-710. doi: 10.1002/ejhf.2795. Epub 2023 Mar 6. PMID: 36781199 Free article.
Use of and association between heart failure pharmacological treatments and outcomes in obese versus non-obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry. Cappelletto C, Stolfo D, Orsini N, Benson L, Rodolico D, Rosano GMC, Dahlström U, Sinagra G, Lund LH, Savarese G. Eur J Heart Fail. 2023 Feb 13. doi: 10.1002/ejhf.2795. Online ahead of print. PMID: 36781199 Free article.
Use of patient-reported outcomes in heart failure: from clinical trials to routine practice. Savarese G, Lindenfeld J, Stolfo D, Adams K, Ahmad T, Desai NR, Ammirati E, Gottlieb SS, Psotka MA, Rosano GMC, Allen LA. Eur J Heart Fail. 2023 Feb;25(2):139-151. doi: 10.1002/ejhf.2778. Epub 2023 Jan 30. PMID: 36644876 Review.
